Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 5/9/2018
SIETES contiene 92557 citas

 
 
<< anterior 21 a 40 de 4365 siguiente >>
Presentar resultados
Seleccionar todas
22. Cita con resumen
Silverman E. STAT Plus: Novartis is the latest big drug maker to exit antibiotic research. STAT Daily Recap 2018:3. [Ref.ID 102708]
23. Cita con resumen
Samper E. ¿Y por qué no una farmacéutica pública?. eldiario.es 2018:19 de abril. [Ref.ID 102705]
24. Cita con resumen
nónimo. FDA Withdraws guidance relating to biosimilar development. DIA Daily 2018:8. [Ref.ID 102702]
25. Cita con resumen
Anónimo. Increasing cost of insulin sparks concern. DIA Daily 2018:1. [Ref.ID 102700]
26. Cita con resumen
Anónimo. Bill And Melinda Gates build A “biotech-within-a-charity”. DIA Daily 2018:1. [Ref.ID 102662]
27.Enlace a cita original Cita con resumen
Hadland SE, Cerdá M, Li Y, Krieger MS, Marshall BDL. Association of pharmaceutical industry marketing of opioid products to physicians with subsequent opioid prescribing. JAMA Intern Med 2018;178:861-3. [Ref.ID 102637]
28.Enlace a cita original Cita con resumen
Liljenquist D, Bai G, Anderson GF. Addressing generic-drug market failures — The case for establishing a nonprofit manufacturer. N Engl J Med 2018;378:17 de mayo. [Ref.ID 102608]
29. Cita con resumen
Hirschler B. Regulators flag possible birth defect link to GSK's HIV drug. Reuters Health News 2018:18 de mayo. [Ref.ID 102606]
30. Cita con resumen
Feuerstein A. After watching Trump’s drug speech, investors poured big money into biotech funds. STAT Daily Recap 2018:4. [Ref.ID 102605]
33. Cita con resumen
Silverman E. Trump’s lawyer pitched himself as a fixer to Novartis and got paid $1.2 million. STAT Daily Recap 2018:1. [Ref.ID 102599]
34.Enlace a cita original Cita con resumen

Se ha producido un error durante la generación de la página

. Novartis paid nearly $400,000 to a shell company controlled by Trump’s attorney. STAT 2018:8 de mayo. [Ref.ID 102598]
35. Cita con resumen
Weintraub A. It's another dust-up over AstraZeneca's CEO pay, this time focused on his bonus. FiercePharma 2018:8 de mayo. [Ref.ID 102597]
36. Cita con resumen
Anónimo. Takeda reaches $62 billion deal to buy shire. DIA Daily 2018:1. [Ref.ID 102596]
39. Cita con resumen
Mole B. “Is curing patients a sustainable business model?” Goldman Sachs analysts ask. Ars Technica 2018:12 de abril. [Ref.ID 102511]
40. Cita con resumen
Rimmer A. Bring me a sunshine act: five minutes with . . . Peter Gordon. BMJ 2018;360:29 de marzo. [Ref.ID 102502]
Seleccionar todas
 
<< anterior 21 a 40 de 4365 siguiente >>